Mar 09
The FDA has announced its approval of Spravato, a ketamine-based nasal spray that can be used with oral antidepressants as a treatment for severe depression. The drug is intended for adults who suffer from treatment-resistant depression and have been unable to find relief through other medications. However, the FDA warns that Spravato’s side effects may result in some potentially “serious … Continue reading
Post a Comment